![](/img/cover-not-exists.png)
EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patient-derived xenografts with cetuximab
Wang, Xiaohong, Fu, Runjia, Hu, Ying, Du, Hong, Li, Shuangxi, Li, Ziyu, Liu, Yiqiang, Li, Qixiang, Zhang, Lianhai, Ji, JiafuVolume:
38
Language:
english
Journal:
Oncology Reports
DOI:
10.3892/or.2017.5907
Date:
April, 2017
File:
PDF, 598 KB
english, 2017